Neuronetics, Inc. ( STIM) - Stock Earnings
STIM Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
STIM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -7.2 million USD | 41.8 million USD |
| 2026Q1 | -10.8 million USD | 34.5 million USD |
| 2026Q2 | -3.4 million USD | 41.6 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
STIM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -30.2 million USD | 71.3 million USD |
| 2024 | -43.7 million USD | 74.9 million USD |
| 2025 | -39.0 million USD | 149.2 million USD |
| 2026 Est. | — | — |
STIM
Price: $1.88
52 week price:
Earnings Per Share: -0.43 USD
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 51584
Market Capitalization: 150.3 million